Form 4: aTyr Pharma Director Jane A. Gross Reports Transaction
SEC Form 4 Filing
Director Jane A. Gross reports the acquisition and disposal of aTyr Pharma Inc. common stock on March 17, 2025.
Summary
- On March 17, 2025, Jane A. Gross, a director of aTyr Pharma Inc., reported a transaction involving the company's common stock.
- Gross acquired 3,750 shares of common stock at a price of $4 per share.
- Following the acquisition, Gross disposed of 9,750 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 03/17/2025 | Date of the reported transaction involving the acquisition and disposal of aTyr Pharma Inc. common stock. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.